Huntington Bancshs【1HU3】銘柄情報 | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
イタリア
BIT
Huntington Bancshs Inc (1HU3) 銘柄情報

Huntington Bancshs Inc (1HU3)

16.004

0.00

(0.00%)

終了 12月14日 1:30AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

16.004

買値

16.162

売値

16.498

出来高

0.00

0.00 日の範囲 0.00

11.60 52 週間の範囲 16.004

時価総額

前日終値

16.004

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

88

発行済株式数

1,452,811,392

配当利回り

4.07%

PER

20.70

1 株当たり利益 (EPS)

1.25

歳入

7.36B

純利益

1.82B

セクター

National Commercial Banks - Non Islamic

業界

National Commercial Banks - Non Islamic

ウェブサイト

www.huntington.com

本社

Columbus, Ohio, USA

設立

-

Huntington Bancshs Inc is listed in the National Commercial Banks - Non Islamic sector of the イタリア証券取引所 with ticker 1HU3. The last closing price for Huntington Bancshs was 16.00 €. Over the last year, Huntington Bancshs shares have traded in a share price range of 11.60 € to 16.004 €.

Huntington Bancshs currently has 1,452,811,392 shares in issue. The market capitalisation of Huntington Bancshs is 23.25 € billion. Huntington Bancshs has a price to earnings ratio (PE ratio) of 20.70.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	1.404	9.61643835616	14.6	16.004	14.182	88	14.85714286	DE
26	1.752	12.2930115072	14.252	16.004	12.702	79	14.26486232	DE
52	4.404	37.9655172414	11.6	16.004	11.6	82	13.8561411	DE
156	4.404	37.9655172414	11.6	16.004	11.6	82	13.8561411	DE
260	4.404	37.9655172414	11.6	16.004	11.6	82	13.8561411	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
WGML25GM Leather spa	0.011 € (29.41%)	5k
WPSQ26Pasquarelli Auto SpA	0.0139 € (28.70%)	252
WERFOLaboratorio Farmaceutico Erfo SPA	0.019 € (27.52%)	20k
WLDB24Lindbergh Spa	0.56 € (24.44%)	15k
1AVGOBroadcom Inc	205.70 € (21.23%)	12.12k
GSRAAG Rent AA	0.005 € (-83.33%)	46.6k
WICC24International Care Company	0.0034 € (-47.69%)	117.39k
EVAAAAskoll Eva AA	0.004 € (-47.37%)	495k
1GPROGoPro Inc	1.167 € (-23.97%)	550
WRDF25Redelfi SpA	1.33 € (-21.75%)	300
TITTelecom Italia SpA	0.2598 € (2.61%)	472.59M
TITRTelecom Italia	0.3007 € (3.09%)	64.37M
ISPIntesa Sanpaolo Spa	3.923 € (0.46%)	46.56M
BPEBper Banca SPA	6.198 € (1.24%)	22.8M
SPMSaipem Spa	2.576 € (0.27%)	22.7M

JD400

Miles Franklin's Schectman interviews GATA secretary about the organization's long journey
Submitted by admin on Fri, 2024-12-13 08:50 Section: Daily Dispatches
8:51a ET Friday, December 13, 2024

Dear Friend of GATA and Gold:

Andy Schectman of the Miles Fr

tulla236a

tulla236a 4分前

it’s whistleblowers season. c’mon citadel and virtu employees. make some money before you lose your jobs. besides you are abetting criminals.

StayHumble

StayHumble 4分前

Mother Earth’s Stores💹Double $HCWC💹Revenue $75Million+💹💹 @healthiercmc
https://www.healthiercmc.com/news/20220210-mother-earths-storehouse
https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMi

JD400

Miles Franklin's Schectman interviews GATA secretary about the organization's long journey
Submitted by admin on Fri, 2024-12-13 08:50 Section: Daily Dispatches
8:51a ET Friday, December 13, 2024

Dear Friend of GATA and Gold:

Andy Schectman of the Miles Fr

StayHumble

StayHumble 6分前

💹🎄$50 POSSIBLE 💹XPERT info>💹https://gncc-capital.com/Highlights.html 💹

ddls

I love it when BIEL's fraudulent past is exposed, because every time the stock deteriorates further.

Thanks Mr.Ed😎

amelia43

amelia43 9分前

I bought at $3 before thanksgiving.

I was thinking the same thing, Every time I buy, you guys should short it. lol….

StayHumble

StayHumble 9分前

SEC💹Catches🎅🏿&👽Artificially Lowering Prices💹2Buy Shares Cheaper wow!!!

6, 12, 2023. —
SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misreprese

cowtown jay

cowtown jay 9分前

As I said at the beginning of this thread, and countless times over the years, "The all-important question is, did Novavax enhance their covid vaccine with Humanigen's patented lenz/vaccine cocktail?"

We know that that the FDA Approved Emergency IND Use of Humanigen’s Lenz in April 2

Riley4

Riley4 10分前

Thx I always wondered how they naked shorted without having to show their hands, really sad, but thx again explains much, best to you Riley

StayHumble

StayHumble 13分前

🇺🇸Hearing a MOASS takes $DJT to MARS🇺🇸huzzah🇺🇸 🇺🇸🇺🇸

bgoat

Thank You the droetdude, spot on, if any of these dil*os,ooops I mean cry babies were serious about anything they would email Sean......just keeping it "real" 😋

StayHumble

StayHumble 16分前

💹Looks Like $PM $HCMC BUYOUT onDECK💹Jury Trial wow💹
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165809518
If this goes to a jury trial, $PM is done and they know it. With all the dead from lung cancer(Marlboro cigarettes) PM will get slammed b

misterfishman

misterfishman 18分前

I hope we get some updates next week.

sab63090

sab63090 18分前

Although this feels like a ping-pong match because of the scientific endpoint results, I'm with you on your thought process!

My thought was that the OLE results are more important right now than waiting for this promised "peer review" which would answer/verify the science, but that

misterfishman

misterfishman 19分前

The otc is full of impatient peeps.

trackkwizzard

trackkwizzard 20分前

"it was pre planned what they've done."
"two month after report its Shares, the company went dark"
Went dark then stayed dark for over a decade. Were we supposed to get discouraged and sell???
Probably, yes.
BECAUSE...competition kept stealing their technology, they had

misterfishman

misterfishman 20分前

Remember peeps the RM is not fully completed yet this is a huge company with hundreds of millions in assets and profits so this play is worth the loooong hold ,be patient and let this play out,at the end of this roller coaster ride the patient ones will be rewarded.

StayHumble

StayHumble 20分前

💹 $9.99! 💹HIGH Sell Orders💹Good Advice💹💹💹💹

dmb2

MHRA has apparently worked down its large review backlog but since MHRA has no committed endpoint for decision as FDA has with PDUFA dates no one can accurately guess an approval date in the UK. The concept of a 150 day review period is currently just a goal for MHRA to achieve and not a reality muc

StayHumble

StayHumble 22分前

💹FilmPopularityXploding Shortly💹Silver investment's Golden💹$AMC

SkeBallLarry

SkeBallLarry 22分前

" G'Morning, Cap'n & Every-One . 80% Rain next 2-3days "

StayHumble

StayHumble 24分前

Power2 the P1ayers💹24/7 interest here💹 💹 💹 💹

Stino2

Stino2 25分前

maybe this stock wil be a hit 😃

Huntington Bancshs

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約